Connect with us

Government

Best Penny Stocks To Buy Now? 4 To Watch As APDN Stock Jumps 230%+

Penny stocks to watch with unusual options activity today.
The post Best Penny Stocks To Buy Now? 4 To Watch As APDN Stock Jumps 230%+ appeared first on…

Published

on

What Are The Best Penny Stocks To Buy Right Now?

It is another wild session in the stock market today, with penny stocks ruling the headlines. Some of the most extensive short squeezes and bullish breakouts have happened over the last few weeks. While HKD and AMTD stock have been surging to the tune of thousands of percentage points. Here are a few articles to check out if you’ve missed the memo:

Then you had more trends stemming from these breakouts, focusing on short squeeze penny stocks, low float penny stocks, and Chinese/Hong Kong tech stocks. Tuesday’s session is no different, and stocks under $5 are still in a very bright spotlight. Applied DNA Sciences (NASDAQ: APDN), for example, skyrocketed early on a major update.

Why APDN Stock Is Up Today

Applied DNA announced that it began analytical validation of a PCR-based monkeypox virus test specific to monkeypox. If the company validates the test, a package will be submitted to the New York State Department of Health for approval.

“Based on our experience with the COVID-19 pandemic, we are keenly aware of the crucial role PCR-based diagnostic tools can play in responding and helping to control public health outbreaks. With a proven workflow and testing services born of COVID-19, upon test approval, ADCL stands ready to apply its testing capacity in service of New Yorkers’ health,” stated Dr. James A. Hayward, president and CEO of Applied DNA Sciences.

Penny Stocks To Watch

Not only is APDN stock running from news catalysts, but it’s also one of the low float penny stocks already on the radar after the last few sessions of bullishness for the micro-niche. Other than perking up interest in APDN stock, it has continued boosting appeal for traders looking for the next round of multibagger penny stocks to buy. Today we look at a few more gaining momentum thanks to a small- and micro-cap stock bull rally this quarter.

  1. Ginkgo Bioworks Holdings (NYSE: DNA)
  2. Bluebird Bio Inc. (NASDAQ: BLUE)
  3. Transocean Limited (NYSE: RIG)
  4. Ironnet Inc. (NASDAQ: IRNT)

Ginkgo Bioworks Holdings (NYSE: DNA)

One of the Cathie Wood penny stocks to watch this year has been Ginkgo Bioworks. One of Wood’s funds, Ark Innovation (NYSEARCA: ARKK), has a position in DNA stock worth about $200 million as of this article. It has also been a company we’ve followed closely since the stock slipped into penny stock territory this year.

Several developments have come to light, prompting a more bullish stand on the penny stock. Whether it was the continued support of the Operation Expanded Testing program with the U.S. CDC or the latest deal to acquire Zymergen Inc. (NASDAQ: ZY), there’s no shortage of recent updates.

What might have traders focused on DNA stock today is some unusual activity in the options market. Yes, some penny stocks have options, and just like higher-priced stocks, irregular activity can spark speculative and sentiment-based trading. As far as the DNA stock options chain goes, it isn’t today’s volume as much as it is the string of open interest that has turned a few heads.

The August Calls alone have more than 25,000 total open contracts compared to far less than that on the puts side of the chain. This trend continues through almost every expiration date through January 2024. Whether or not this is truly a bullish sign is to be seen. For now, however, it has prompted some optimism in the stock market today for DNA stock.

Bluebird Bio Inc. (NASDAQ: BLUE)

Like DNA stock, Bluebird Bio also has some interesting options statistics to consider. Its options chain favors Call open interest compared to puts at or greater than 2:1 at most expiration dates. This week, analysts at Raymond James also gave the biotech company an upgrade to Outperform. The firm announced an $8 target to pair with the new rating. Considering that’s roughly 100% higher than current levels, Raymond James appears bullish on the company.

Bluebird Bio made headlines earlier this summer after the FDA’s Advisory Committee unanimously backed its gene therapy for a rare blood disorder. If approved, the treatment (beti-cel) will become the first potentially curative gene therapy for beta-thalassemia. The same committee endorsed approval of Bluebird’s other gene therapy, elivaldogene autotemcel (eli-cel) a day prior. The treatment is for a rare neurological disease and came into focus despite concerns that the treatment may cause cancer.

[Read More] Penny Stocks To Buy Now? 3 To Watch After LTRPB Stock Jumped Over 372%

This month could be an important one for BLUE stock. That’s because a PDUFA goal date is set for August 19th. The question is, will options traders’ bets be right about the penny stock?

best penny stocks to buy APDN stock Bluebird Bio BLUE stock

Transocean Limited (NYSE: RIG)

You will notice this unusual options activity trend throughout the article, and Transocean is part of it. From the most near-term expiration date, August 5th, to November 18th, Call activity is heightened. Both Open Interest and today’s trading volumes are building steam.

Energy stocks are red hot this quarter, and Transocean is gaining momentum. This week the company announced its latest development. The company’s Deepwater Conqueror drillship was awarded a two-year contract valued at $321 million. This was in addition to announcing a $915 million agreement for its ultra-deepwater Petrobras 10000, which received a 5.8-year contract for offshore work in Brazil.

Given the more than $1 billion in new contracts in addition to a strong energy market & bullish options activity, RIG stock could be one on the watch list right now.

best penny stocks to buy APDN stock Transocean Limited RIG stock

Ironnet Inc. (NASDAQ: IRNT)

While most of the names on this list of penny stocks have unusual options activity for near and longer-term timeframes, Ironnet’s is very much near-term. The August 5th (Friday) $2.50 strike Calls are the ones in question today. More than 5,500 contracts were traded compared to just 841 Open Interest contracts.

The cyber defense technology company recently inked a deal with Brookdale Community College to protect it against cyberattacks. “The education sector is now a primary target for cyber attacks, putting our next generation at risk. We need leaders across school districts, colleges, and universities to work together to protect this critical sector from further attacks,” said General (Ret.) Keith Alexander, co-CEO and founder of IronNet. “As a top community college in the U.S., Brookdale is taking a proactive stance against bad actors by partnering with IronNet to not only defend its networks against real-time attacks but also strengthen the security posture of the entire education community.”

Cybersecurity stocks have come back into focus in light of the latest cyberattack on Taiwan’s presidential office ahead of Nancy Pelosi’s visit. Whether or not the bullish options activity is tied to this sentiment is a guess at this point. But, for now, it may be something to keep in mind if IRNT stock is on your watch list.

best penny stocks to buy APDN stock Ironnet Inc. IRNT stock

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!

The post Best Penny Stocks To Buy Now? 4 To Watch As APDN Stock Jumps 230%+ appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

Spread & Containment

Many CDC Blunders Exaggerated Severity Of COVID-19: Study

Many CDC Blunders Exaggerated Severity Of COVID-19: Study

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

The U.S. Centers…

Published

on

Many CDC Blunders Exaggerated Severity Of COVID-19: Study

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

The U.S. Centers for Disease Control and Prevention (CDC) made at least 25 statistical or numerical errors during the COVID-19 pandemic, and the overwhelming majority exaggerated the severity of the pandemic, according to a new study.

Researchers who have been tracking CDC errors compiled 25 instances where the agency offered demonstrably false information. For each instance, they analyzed whether the error exaggerated or downplayed the severity of COVID-19.

Of the 25 instances, 20 exaggerated the severity, the researchers reported in the study, which was published ahead of peer review on March 23.

The CDC has expressed significant concern about COVID-19 misinformation. In order for the CDC to be a credible source of information, they must improve the accuracy of the data they provide,” the authors wrote.

The CDC did not respond to a request for comment.

Most Errors Involved Children

Most of the errors were about COVID-19’s impact on children.

In mid-2021, for instance, the CDC claimed that 4 percent of the deaths attributed to COVID-19 were kids. The actual percentage was 0.04 percent. The CDC eventually corrected the misinformation, months after being alerted to the issue.

CDC Director Dr. Rochelle Walensky falsely told a White House press briefing in October 2021 that there had been 745 COVID-19 deaths in children, but the actual number, based on CDC death certificate analysis, was 558.

Walensky and other CDC officials also falsely said in 2022 that COVID-19 was a top five cause of death for children, citing a study that gathered CDC data instead of looking at the data directly. The officials have not corrected the false claims.

Other errors include the CDC claiming in 2022 that pediatric COVID-19 hospitalizations were “increasing again” when they’d actually peaked two weeks earlier; CDC officials in 2023 including deaths among infants younger than 6 months old when reporting COVID-19 deaths among children; and Walensky on Feb. 9, 2023, exaggerating the pediatric death toll before Congress.

“These errors suggest the CDC consistently exaggerates the impact of COVID-19 on children,” the authors of the study said.

Read more here...

Tyler Durden Fri, 03/24/2023 - 20:20

Read More

Continue Reading

Government

NIH awards researchers $7.5 million to create data support center for opioid use disorder and pain management research

WINSTON-SALEM, N.C. – March 24, 2023 – Researchers at Wake Forest University School of Medicine have been awarded a five-year, $7.5 million grant…

Published

on

WINSTON-SALEM, N.C. – March 24, 2023 – Researchers at Wake Forest University School of Medicine have been awarded a five-year, $7.5 million grant from the National Institutes of Health (NIH) Helping End Addiction Long-term (HEAL) initiative.

Credit: Wake Forest University School of Medicine

WINSTON-SALEM, N.C. – March 24, 2023 – Researchers at Wake Forest University School of Medicine have been awarded a five-year, $7.5 million grant from the National Institutes of Health (NIH) Helping End Addiction Long-term (HEAL) initiative.

The NIH HEAL initiative, which launched in 2018, was created to find scientific solutions to stem the national opioid and pain public health crises. The funding is part of the HEAL Data 2 Action (HD2A) program, designed to use real-time data to guide actions and change processes toward reducing overdoses and improving opioid use disorder treatment and pain management.

With the support of the grant, researchers will create a data infrastructure support center to assist HD2A innovation projects at other institutions across the country. These innovation projects are designed to address gaps in four areas—prevention, harm reduction, treatment of opioid use disorder and recovery support.

“Our center’s goal is to remove barriers so that solutions can be more streamlined and rapidly distributed,” said Meredith C.B. Adams, M.D., associate professor of anesthesiology, biomedical informatics, physiology and pharmacology, and public health sciences at Wake Forest University School of Medicine.

By monitoring opioid overdoses in real time, researchers will be able to identify trends and gaps in resources in local communities where services are most needed.

“We will collect and analyze data that will inform prevention and treatment services,” Adams said. “We’re shifting chronic pain and opioid care in communities to quickly offer solutions.”

The center will also develop data related resources, education and training related to substance use, pain management and the reduction of opioid overdoses.

According to the CDC, there was a 29% increase in drug overdose deaths in the U.S.  in 2020, and nearly 75% of those deaths involved an opioid.

“Given the scope of the opioid crises, which was only exacerbated by the COVID-19 pandemic, it’s imperative that we improve and create new prevention strategies,” Adams said. “The funding will create the infrastructure for rapid intervention.”


Read More

Continue Reading

International

How They Convinced Trump To Lock Down

How They Convinced Trump To Lock Down

Authored by Jeffrey A. Tucker via Brownstone Institute,

An enduring mystery for three years is how…

Published

on

How They Convinced Trump To Lock Down

Authored by Jeffrey A. Tucker via Brownstone Institute,

An enduring mystery for three years is how Donald Trump came to be the president who shut down American society for what turned out to be a manageable respiratory virus, setting off an unspeakable crisis with waves of destructive fallout that continue to this day. 

Let’s review the timeline and offer some well-founded speculations about what happened. 

On March 9, 2020, Trump was still of the opinion that the virus could be handled by normal means. 

Two days later, he changed his tune. He was ready to use the full power of the federal government in a war on the virus. 

What changed? Deborah Birx reports in her book that Trump had a friend die in a New York hospital and this is what shifted his opinion. Jared Kushner reports that he simply listened to reason. Mike Pence says he was persuaded that his staff would respect him more. No question (and based on all existing reports) that he found himself surrounded by “trusted advisors” amounting to about 5 or so people (including Mike Pence and Pfizer board member Scott Gottlieb)

It was only a week later when Trump issued the edict to close all “indoor and outdoor venues where people congregate,” initiating the biggest regime change in US history that flew in the face of all rights and liberties Americans had previously taken for granted. It was the ultimate in political triangulation: as John F. Kennedy cut taxes, Nixon opened China, and Clinton reformed welfare, Trump shut down the economy he promised to revive. This action confounded critics on all sides. 

A month later, Trump said his decision to have “turned off” the economy saved millions of lives, later even claiming to have saved billions. He has yet to admit error. 

Even as late as June 23rd of that year, Trump was demanding credit for having followed all of Fauci’s recommendations. Why do they love him and hate me, he wanted to know. 

Something about this story has never really added up. How could one person have been so persuaded by a handful of others such as Fauci, Birx, Pence, and Kushner and his friends? He surely had other sources of information – some other scenario or intelligence – that fed into his disastrous decision. 

In one version of events, his advisors simply pointed to the supposed success of Xi Jinping in enacting lockdowns in Wuhan, which the World Health Organization claimed had stopped infections and brought the virus under control. Perhaps his advisors flattered Trump with the observation that he is at least as great as the president of China so he should be bold and enact the same policies here. 

One problem with this scenario is timing. The Oval Office meetings that preceded his March 16, 2020, edict took place the weekend of the 14th and 15th, Friday and Saturday. It was already clear by the 11th that Trump was ready for lockdowns. This was the same day as Fauci’s deliberately misleading testimony to the House Oversight Committee in which he rattled the room with predictions of Hollywood-style carnage. 

On the 12th, Trump shut all travel from Europe, the UK, and Australia, causing huge human pile-ups at international airports. On the 13th, the Department of Health and Human Services issued a classified document that transferred control of pandemic policy from the CDC to the National Security Council and eventually the Department of Homeland Security. By the time that Trump met with Fauci and Birx in that legendary weekend, the country was already under quasi-martial law. 

Isolating the date in the trajectory here, it is apparent that whatever happened to change Trump occurred on March 10, 2020, the day after his Tweet saying there should be no shutdowns and one day before Fauci’s testimony. 

That something very likely revolves around the most substantial discovery we’ve made in three years of investigations. It was Debbie Lerman who first cracked the code: Covid policy was forged not by the public-health bureaucracies but by the national-security sector of the administrative state. She has further explained that this occurred because of two critical features of the response: 1) the belief that this virus came from a lab leak, and 2) the vaccine was the biosecurity countermeasure pushed by the same people as the fix. 

Knowing this, we gain greater insight into 1) why Trump changed his mind, 2) why he has never explained this momentous decision and otherwise completely avoids the topic, and 3) why it has been so unbearably difficult to find out any information about these mysterious few days other than the pablum served up in books designed to earn royalties for authors like Birx, Pence, and Kushner. 

Based on a number of second-hand reports, all available clues we have assembled, and the context of the times, the following scenario seems most likely. On March 10, and in response to Trump’s dismissive tweet the day before, some trusted sources within and around the National Security Council (Matthew Pottinger and Michael Callahan, for example), and probably involving some from military command and others, came to Trump to let him know a highly classified secret. 

Imagine a scene from Get Smart with the Cone of Silence, for example. These are the events in the life of statecraft that infuse powerful people with a sense of their personal awesomeness. The fate of all of society rests on their shoulders and the decisions they make at this point. Of course they are sworn to intense secrecy following the great reveal. 

The revelation was that the virus was not a textbook virus but something far more threatening and terrible. It came from a research lab in Wuhan. It might in fact be a bioweapon. This is why Xi had to do extreme things to protect his people. The US should do the same, they said, and there is a fix available too and it is being carefully guarded by the military. 

It seems that the virus had already been mapped in order to make a vaccine to protect the population. Thanks to 20 years of research on mRNA platforms, they told him,  this vaccine can be rolled out in months, not years. That means that Trump can lock down and distribute vaccines to save everyone from the China virus, all in time for the election. Doing this would not only assure his reelection but guarantee that he would go down in history as one of the greatest US presidents of all time. 

This meeting might only have lasted an hour or two – and might have included a parade of people with the highest-level security clearances – but it was enough to convince Trump. After all, he had battled China for two previous years, imposing tariffs and making all sorts of threats. It was easy to believe at that point that China might have initiated biological warfare as retaliation. That’s why he made the decision to use all the power of the presidency to push a lockdown under emergency rule. 

To be sure, the Constitution does not allow him to override the discretion of the states but with the weight of the office complete with enough funding and persuasion, he could make it happen. And thus did he make the fateful decision that not only wrecked his presidency but the country too, imposing harms that will last a generation. 

It only took a few weeks for Trump to become suspicious about what happened. For weeks and months, he toggled between believing that he was tricked and believing that he did the right thing. He had already approved another 30 days of lockdowns and even inveighed against Georgia and later Florida for opening. He went so far as to claim that no state could open without his approval. 

He did not fully change his mind until August, when Scott Atlas revealed the whole con to him. 

There is another fascinating feature to this entirely plausible scenario. Even as Trump’s advisors were telling him that this could be a bioweapon leaked from the lab in China, we had Anthony Fauci and his cronies going to great lengths to deny it was a lab leak (even if they believed that it was). This created an interesting situation. The NIH and those surrounding Fauci were publicly insisting that the virus was of zoonotic origin, even as Trump’s circle was telling the president that it should be regarded as a bioweapon. 

Fauci belonged to both camps, which suggests that Trump very likely knew of Fauci’s deception all along: the “noble lie” to protect the public from knowing the truth. Trump had to be fine with that. 

Gradually following the lockdown edicts and the takeover by the Department of Homeland Security, in cooperation with a very hostile CDC, Trump lost power and influence over his own government, which is why his later Tweets urging a reopening fell on deaf ears. To top it off, the vaccine failed to arrive in time for the election. This is because Fauci himself delayed the rollout until after the election, claiming that the trials were not racially diverse enough. Thus Trump’s gambit completely failed, despite all the promises of those around him that it was a guaranteed way to win reelection.

To be sure, this scenario cannot be proven because the entire event – certainly the most dramatic political move in at least a generation and one with unspeakable costs for the country – remains cloaked in secrecy. Not even Senator Rand Paul can get the information he needs because it remains classified. If anyone thinks the Biden approval of releasing documents will show what we need, that person is naive. Still, the above scenario fits all available facts and it is confirmed by second-hand reports from inside the White House. 

It’s enough for a great movie or a play of Shakespearean levels of tragedy. And to this day, none of the main players are speaking openly about it. 

Jeffrey A. Tucker is Founder and President of the Brownstone Institute. He is also Senior Economics Columnist for Epoch Times, author of 10 books, including Liberty or Lockdown, and thousands of articles in the scholarly and popular press. He speaks widely on topics of economics, technology, social philosophy, and culture.

Tyler Durden Fri, 03/24/2023 - 17:40

Read More

Continue Reading

Trending